<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02393495</url>
  </required_header>
  <id_info>
    <org_study_id>22012015</org_study_id>
    <nct_id>NCT02393495</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Intra-uterine Device Insertion</brief_title>
  <official_title>A Further Step Towards Painless Intrauterine Device Insertion, a Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Woman's Health University Hospital, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Woman's Health University Hospital, Egypt</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different studies have been made in an attempt to reduce the pain and the duration of the
      process of outpatient insertion of the intrauterine device. in this trial, the investigators
      aim to insert the IUD under ultrasonographic guidance, which can help to reduce the pain,
      decrease the process of insertion, in addition, it reduces the incidence of malposition of
      IUD as well as the risk of complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of degree of pain during IUD insertion</measure>
    <time_frame>6 months</time_frame>
    <description>Pain will be assessed by the use of visual analog scale, Pain rating scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Ultrasound guided group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the female will be asked to be full bladder. the trans-abdominal probe will be placed by an assistant on the suprapubic region. under speculum examination, the intrauterine device IUD (TCu 380A) will be placed till it reaches the fundus of the uterus and then released.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non ultrasound guided group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the intrauterine device TCu 380A will be inserted in the conventional method, and checked afterwards by transvaginal ultrasound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intrauterine device TCu 380A</intervention_name>
    <arm_group_label>Ultrasound guided group</arm_group_label>
    <arm_group_label>Non ultrasound guided group</arm_group_label>
    <other_name>TCu 380A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females desiring contraception with the use of IUD

        Exclusion Criteria:

          -  Are pregnant or think they may be pregnant

          -  Septic pregnancy or abortion

          -  Have unexplained abnormal vaginal bleeding

          -  Have untreated cervical cancer

          -  Have malignant gestational trophoblastic disease

          -  Have uterine cancer

          -  Have uterine abnormalities

          -  Have or may have had a pelvic infection within the past three months

          -  Have or may have any sexually transmitted disease

          -  Have pelvic tuberculosis

          -  Are postpartum between 48 hours and 4 weeks

          -  Have benign gestational trophoblastic disease

          -  Have ovarian cancer

          -  Have AIDS (unless clinically well on anti-retroviral therapy)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina MR Dakhly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr el ainy hospital</name>
      <address>
        <city>Cairo</city>
        <zip>12211</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>August 30, 2015</last_update_submitted>
  <last_update_submitted_qc>August 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Woman's Health University Hospital, Egypt</investigator_affiliation>
    <investigator_full_name>Dina Mohamed Refaat Dakhly</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

